Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 951 JPY -1.86% Market Closed
Market Cap: 26.7B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Total Current Liabilities
ÂĄ23.2B
CAGR 3-Years
28%
CAGR 5-Years
58%
CAGR 10-Years
60%
GNI Group Ltd
TSE:2160
Total Current Liabilities
ÂĄ10.9B
CAGR 3-Years
68%
CAGR 5-Years
32%
CAGR 10-Years
47%
PeptiDream Inc
TSE:4587
Total Current Liabilities
ÂĄ16.8B
CAGR 3-Years
81%
CAGR 5-Years
68%
CAGR 10-Years
67%
Takara Bio Inc
TSE:4974
Total Current Liabilities
ÂĄ7.8B
CAGR 3-Years
-23%
CAGR 5-Years
8%
CAGR 10-Years
5%
S
StemRIM Inc
TSE:4599
Total Current Liabilities
ÂĄ67.5m
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Total Current Liabilities
ÂĄ166m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.7B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 625.98 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Total Current Liabilities?
Total Current Liabilities
23.2B JPY

Based on the financial report for Jul 31, 2024, Pharma Foods International Co Ltd's Total Current Liabilities amounts to 23.2B JPY.

What is Pharma Foods International Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
60%

Over the last year, the Total Current Liabilities growth was -5%. The average annual Total Current Liabilities growth rates for Pharma Foods International Co Ltd have been 28% over the past three years , 58% over the past five years , and 60% over the past ten years .

Back to Top